Molecular dynamics and preparation of a liposome-loaded polymeric nanofilm to enhance the transdermal permeation of mupirocin
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Lipid Membrane Structure and Behavior · Polydiacetylene-based materials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (64)
Show source-provided references
1. Hindy J-R, Haddad SF, Kanj SS (2022) New drugs for methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Curr Opin Infect Dis 35:112–11910.1097/QCO.0000000000000800 ↗
2. Miller LS, Cho JS (2011) Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol 11:505–51810.1038/nri3010 ↗
3. Lipsky BA, Hoey C (2009) Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis 49:1541–154910.1086/644732 ↗
4. Leaper D, Assadian O, Edmiston CE (2015) Approach to chronic wound infections. Br J Dermatol 173:351–35810.1111/bjd.13677 ↗
5. Najm MB, Rawas-Qalaji M, Assar NH, Yahia R, El Hosary R, Ahmed IS (2022) Optimization, characterization and in vivo evaluation of mupirocin nanocrystals for topical administration. Eur J Pharm Sci 176:10625110.1016/j.ejps.2022.106251 ↗
6. Poovelikunnel T, Gethin G, Humphreys H (2015) Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA. J Antimicrob Chemother 70:2681–269210.1093/jac/dkv169 ↗
7. Khoshnood S, Heidary M, Asadi A, Soleimani S, Motahar M, Savari M, Saki M, Abdi M (2019) A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus. Biomed Pharmacother 109:1809–181810.1016/j.biopha.2018.10.131 ↗
8. Perumal S, Ramadass Sk, Madhan B (2014) Sol–gel processed mupirocin silica microspheres loaded collagen scaffold: a synergistic bio-composite for wound healing. Eur J Pharm Sci 52:26–3310.1016/j.ejps.2013.10.006 ↗
9. Okur NÜ, Hökenek N, Okur ME, Ayla Ş, Yoltaş A, Siafaka PI, Cevher E (2019) An alternative approach to wound healing field; new composite films from natural polymers for mupirocin dermal delivery. Saudi Pharm J 27:738–75210.1016/j.jsps.2019.04.010 ↗
10. Junghanns J-UA, Müller RH (2008) Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed 3:295
11. Mishra PR, Al Shaal L, Müller RH, Keck CM (2009) Production and characterization of Hesperetin nanosuspensions for dermal delivery. Int J Pharm 371:182–18910.1016/j.ijpharm.2008.12.030 ↗
12. Müller RH, Gohla S, Keck CM (2011) State of the art of nanocrystals–special features, production, nanotoxicology aspects and intracellular delivery. Eur J Pharm Biopharm 78:1–910.1016/j.ejpb.2011.01.007 ↗
13. Smith R, Russo J, Fiegel J, Brogden N (2020) Antibiotic delivery strategies to treat skin infections when innate antimicrobial defense fails. Antibiotics 9:5610.3390/antibiotics9020056 ↗
14. Sun T, Zhang YS, Pang B et al (2021) Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl 53:12320–6410.1002/anie.201403036 ↗
15. Jha S, K. Sharma P, Malviya R (2016) Liposomal drug delivery system for cancer therapy: Advancement and patents. Recent Pat Drug Deliv Formul 10:177–18310.2174/1872211310666161004155757 ↗
16. Rukavina Z, Vanić Ž (2016) Current trends in development of liposomes for targeting bacterial biofilms. Pharmaceutics 8:1810.3390/pharmaceutics8020018 ↗
17. Khaledian S, Abdoli M, Shahlaei M, Behbood L, Kahrizi D, Arkan E, Moradi S (2020) Two-dimensional nanostructure colloids in novel nano drug delivery systems. Colloids Surf A Physicochem Eng Asp 585:12407710.1016/j.colsurfa.2019.124077 ↗
18. Hemeg HA (2017) Nanomaterials for alternative antibacterial therapy. Int J Nanomedicine 12:821110.2147/IJN.S132163 ↗
19. Peppas NA, Hilt JZ, Khademhosseini A, Langer R (2006) Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv Mater 18:1345–136010.1002/adma.200501612 ↗
20. Ullah N, Khan D, Ahmed N, Zafar A, Shah KU, ur Rehman A (2023) Lipase-sensitive fusidic acid polymeric nanoparticles based hydrogel for on-demand delivery against MRSA-infected burn wounds. J Drug Deliv Sci Technol 80:10411010.1016/j.jddst.2022.104110 ↗
21. Zafar A, Khan D, ur Rehman A, Ullah N, Ur-Rehman T, Ahmad NM, Ahmed N (2023) Fabrication of bergenin nanoparticles based hydrogel against infected wounds: an in vitro and in vivo study. J Drug Deliv Sci Technol 82:10436410.1016/j.jddst.2023.104364 ↗
22. Khan SA, Ahmed N, Khan D, Bibi A, ur Rehman A (2024) pH-responsive mupirocin-loaded hybrid nanoparticles in hydrogel and film forming spray against resistant bacterial wound infections. Journal of Drug Delivery Science and Technology 101:10618710.1016/j.jddst.2024.106187 ↗
23. Baier G, Cavallaro A, Vasilev K et al (2013) Enzyme responsive hyaluronic acid nanocapsules containing polyhexanide and their exposure to bacteria to prevent infection. Biomacromolecules 14:1103–111210.1021/bm302003m ↗
24. Hamidi M, Azadi A, Rafiei P (2008) Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 60:1638–164910.1016/j.addr.2008.08.002 ↗
25. Sokolsky-Papkov M, Agashi K, Olaye A, Shakesheff K, Domb AJ (2007) Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 59:187–20610.1016/j.addr.2007.04.001 ↗
26. Liu S, Jiang T, Guo R, Li C, Lu C, Yang G, Nie J, Wang F, Yang X, Chen Z (2021) Injectable and degradable PEG hydrogel with antibacterial performance for promoting wound healing. ACS Appl Bio Mater 4:2769–278010.1021/acsabm.1c00004 ↗
27. Asvar Z, Nowroozi G, Jalali P, Rahmani S, Moradi S (2025) Investigating the effects of cholesterol and lipid purity on phospholipid stability in liposomal nanocarriers using molecular dynamics simulations. J Rep Pharm Sci 13:e161931. https://doi.org/10.5812/jrps-16193110.5812/jrps-161931 ↗
28. Moradi S, Nowroozi A, Nezhad MA, Jalali P, Khosravi R, Shahlaei M (2024) A review on description dynamics and conformational changes of proteins using combination of principal component analysis and molecular dynamics simulation. Comput Biol Med 183:10924510.1016/j.compbiomed.2024.109245 ↗
29. Van Der Spoel D, Lindahl E, Hess B et al (2005) GROMACS: fast, flexible, and free. J Comput Chem 26:1701–171810.1002/jcc.20291 ↗
30. Oostenbrink C, Villa A, Mark AE, Van Gunsteren WF (2004) A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6. J Comput Chem 25:1656–167610.1002/jcc.20090 ↗
31. Mark P, Nilsson L (2001) Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J Phys Chem A 105:9954–996010.1021/jp003020w ↗
32. Fletcher R, Powell MJ (1963) A rapidly convergent descent method for minimization. Comput J 6:163–16810.1093/comjnl/6.2.163 ↗
33. Bussi G, Donadio D, Parrinello M (2007) Canonical sampling through velocity rescaling. J Chem Phys. https://doi.org/10.1063/1.240842010.1063/1.2408420 ↗
34. Parrinello M, Rahman A (1980) Crystal structure and pair potentials: a molecular-dynamics study. Phys Rev Lett 45:119610.1103/PhysRevLett.45.1196 ↗
35. Hess B, Bekker H, Berendsen HJ, Fraaije JG (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18:1463–147210.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H ↗
36. Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N⋅ log (N) method for Ewald sums in large systems. J Chem Phys 98:10089–1009210.1063/1.464397 ↗
37. Kumari R, Kumar R, Consortium OSDD, Lynn A (2014) g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 54:1951–196210.1021/ci500020m ↗
38. Allen WJ, Lemkul JA, Bevan DR (2009) GridMAT-MD: a grid-based membrane analysis tool for use with molecular dynamics. J Comput Chem 30:1952–195810.1002/jcc.21172 ↗
39. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33–3810.1016/0263-7855(96)00018-5 ↗
40. Pavelić Ž, Škalko-Basnet N, Schubert R (2001) Liposomal gels for vaginal drug delivery. Int J Pharm 219:139–14910.1016/S0378-5173(01)00637-8 ↗
41. Feiz S, Navarchian AH (2019) Poly (vinyl alcohol) hydrogel/chitosan-modified clay nanocomposites for wound dressing application and controlled drug release. Macromol Res 27:290–30010.1007/s13233-019-7046-z ↗
42. Tamahkar E, Özkahraman B (2015) Potential evaluation of PVA-based hydrogels for biomedical applications. Hittite J Sci Eng 2:165–17110.17350/HJSE19030000021 ↗
43. Nowroozi G, Rahmani S, Jalali P, Zareie A, Asvar Z, Nowroozi A (2025) Natural marine-derived compounds as potential inhibitors of SARS-CoV-2 main protease: a comprehensive computational study. Journal of Reports in Pharmaceutical Sciences 13:e16519010.5812/jrps-159451 ↗
44. Moradi S, Taran M, Mohajeri P, Sadrjavadi K, Sarrami F, Karton A, Shahlaei M (2018) Study of dual encapsulation possibility of hydrophobic and hydrophilic drugs into a nanocarrier based on bio-polymer coated graphene oxide using density functional theory, molecular dynamics simulation and experimental methods. J Mol Liq 262:204–21710.1016/j.molliq.2018.04.089 ↗
45. Moeini A, Pedram P, Makvandi P, Malinconico M, d’Ayala GG (2020) Wound healing and antimicrobial effect of active secondary metabolites in chitosan-based wound dressings: a review. Carbohydr Polym 233:11583910.1016/j.carbpol.2020.115839 ↗
46. Moradi S, Nowroozi A, Shahlaei M (2019) Shedding light on the structural properties of lipid bilayers using molecular dynamics simulation: a review study. RSC Adv 9:4644–465810.1039/C8RA08441F ↗
47. Khajeh A, Modarress H (2014) Effect of cholesterol on behavior of 5-fluorouracil (5-FU) in a DMPC lipid bilayer, a molecular dynamics study. Biophys Chem 187:43–5010.1016/j.bpc.2014.01.004 ↗
48. Siler-Marinkovic S (2016) Liposomes as drug delivery systems in dermal and transdermal drug delivery. In: Dragicevic N, Maibach H (eds) Percutaneous penetration enhancers chemical methods in penetration enhancement. Springer, Berlin, Heidelberg, pp 15–38. https://doi.org/10.1007/978-3-662-47862-2_210.1007/978-3-662-47862-2_2 ↗
49. Wilson B, Samanta MK, Santhi K, Kumar KS, Ramasamy M, Suresh B (2010) Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Nanomedicine Nanotechnol Biol Med 6:144–15210.1016/j.nano.2009.04.001 ↗
50. Abdulbaqi IM, Darwis Y, Khan NAK, Assi RA, Khan AA (2016) Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomedicine. https://doi.org/10.2147/IJN.S10501610.2147/IJN.S105016 ↗
51. Kumar A, Dixit CK (2017) Methods for characterization of nanoparticles. In: Advances in nanomedicine for the delivery of therapeutic nucleic acids. Elsevier, Woodhead Publishing Sawston, Cambridge, pp 43–58. https://doi.org/10.1016/B978-0-08-100557-6.00003-110.1016/B978-0-08-100557-6.00003-1 ↗
52. Ramasamy T, Khandasami US, Ruttala H, Shanmugam S (2012) Development of solid lipid nanoparticles enriched hydrogels for topical delivery of anti-fungal agent. Macromol Res 20:682–69210.1007/s13233-012-0107-1 ↗
53. Rajati H, Alvandi H, Rahmatabadi SS, Hosseinzadeh L, Arkan E (2023) A nanofiber-hydrogel composite from green synthesized AgNPs embedded to PEBAX/PVA hydrogel and PA/Pistacia atlantica gum nanofiber for wound dressing. Int J Biol Macromol 226:1426–144310.1016/j.ijbiomac.2022.11.255 ↗
54. Asvar Z, Pirbonyeh N, Emami A, Hashemi S-S, Fadaie M, Ebrahiminezhad A, Mirzaei E (2024) Enhancing antibacterial activity against multi-drug resistant wound bacteria: incorporating multiple nanoparticles into chitosan-based nanofibrous dressings for effective wound regeneration. J Drug Deliv Sci Technol 95:10554210.1016/j.jddst.2024.105542 ↗
55. Shemesh M, Zilberman M (2014) Structure–property effects of novel bioresorbable hybrid structures with controlled release of analgesic drugs for wound healing applications. Acta Biomater 10:1380–139110.1016/j.actbio.2013.11.025 ↗
56. Wang R, Zhou B, Xu D-L, Xu H, Liang L, Feng X-H, Ouyang P-K, Chi B (2016) Antimicrobial and biocompatible ε-polylysine–γ-poly (glutamic acid)–based hydrogel system for wound healing. J Bioact Compat Polym 31:242–25910.1177/0883911515610019 ↗
57. Tanuma H, Saito T, Nishikawa K, Dong T, Yazawa K, Inoue Y (2010) Preparation and characterization of PEG-cross-linked chitosan hydrogel films with controllable swelling and enzymatic degradation behavior. Carbohydr Polym 80:260–26510.1016/j.carbpol.2009.11.022 ↗
58. Hurler J, Berg OA, Skar M, Conradi AH, Johnsen PJ, Škalko-Basnet N (2012) Improved burns therapy: liposomes-in-hydrogel delivery system for mupirocin. J Pharm Sci 101:3906–391510.1002/jps.23260 ↗
59. Giordani B, Costantini PE, Fedi S, Cappelletti M, Abruzzo A, Parolin C, Foschi C, Frisco G, Calonghi N, Cerchiara T (2019) Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains. Eur J Pharm Biopharm 139:246–25210.1016/j.ejpb.2019.04.011 ↗
60. Hemmingsen LM, Giordani B, Pettersen AK, Vitali B, Basnet P, Škalko-Basnet N (2021) Liposomes-in-chitosan hydrogel boosts potential of chlorhexidine in biofilm eradication in vitro. Carbohydr Polym 262:11793910.1016/j.carbpol.2021.117939 ↗
61. Kamlungmak S, Wonglapsuwan M, Surachat K, Deachamag P, Srichana T (2022) Bioactivity of mupirocin nanoparticle-loaded hydrogel against methicillin-resistant Staphylococcus aureus (MRSA). Appl Microbiol 2:260–27110.3390/applmicrobiol2010019 ↗
62. Gangwar A, Kumar P, Singh R, Kush P (2021) Recent advances in mupirocin delivery strategies for the treatment of bacterial skin and soft tissue infection. Future Pharmacol 1:80–10310.3390/futurepharmacol1010007 ↗
63. Bhat R, Dogra A, Chib S, Kumar M, Khan IA, Nandi U, Saran S (2024) Development of mupirocin-impregnated bacterial cellulosic transdermal patches for the management of skin infection. ACS Omega 9:5496–550810.1021/acsomega.3c07174 ↗
64. Twilley D, Reva O, Meyer D, Lall N (2022) Mupirocin promotes wound healing by stimulating growth factor production and proliferation of human keratinocytes. Front Pharmacol 13:86211210.3389/fphar.2022.862112 ↗